Development of human metabolomic profiling methods using a combination of high-performance tools (mass spectrometry + machine learning) and genetic editing (CRISPR-Cas).
Ai-Genetika Inc.
12 enregistrements totalisant 1,239,285.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $1,236,194 | 11 enregistrements |
| Affaires mondiales Canada | $3,091 | 1 enregistrement |
Enregistrements
Creation of virtual human twins using patients' metabolomic profiles and artificial intelligence to detect and predict early cancer development and help healthcare professionals.
Development of a diagnostic tool for different types and stages of cancers.
Development of a standard operating procedure to generate robust CRISPR-Cas assay data. This data will be used to train machine learning algorithms for the detection and prediction of on/off target ef...
Development of models and algorithms in machine learning.
Characterization and implementation of new systems for targeted genome editing by CRISPR-Cas9 systems.
Development of artificial intelligence tools to link different biomarkers to the health status of individuals.
Development of artificial intelligence tools to link different biomarkers to the health status of individuals.
Business development support
The project will fund the development of the firm's intellectual property capacity
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research...